Abstract
Allosteric SHP2 inhibitors are a novel class of compounds that target hyperactive Ras/Mitogen Activated Protein Kinase (MAPK) signaling. In this issue......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
